Financials

News Discussions Technicals Seasonals

0NWK fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to VALERIO THERAPEUTICS EUR0.25 operating, investing, and financing activities

0NWK free cash flow for H1 24 is -6.87 M EUR. For 2023, 0NWK free cash flow was -18.78 M EUR and operating cash flow was -18.6 M EUR.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: EUR

TTM

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—